Skip to main content
# Title Department Research Year
2351 Improvement of Solubility and Dissolution Rate of
Indomethacin by Solid Dispersions in Gelucire 50/13 and
PEG4000
Department of Pharmaceutics 2009
2352 Formulation of ketorlac tromethamine in semi-solid dosage forms. Department of Pharmaceutics 2009
2353 Potent Small Molecule murine CD22-Inhibitors: Exploring the Interaction of the residue at C-2 of Sialic Acid Scaffold Department of Pharmaceutical Organic Chemistry 2009
2354 Slit2–Robo4 Signalling Promotes Vascular Stability by
Blocking Arf6 Activity
Department of Pharmaceutical Organic Chemistry 2009
2355 Synthesis, Anti-Bronchoconstrictive, and Antibacterial Activities of some new 8-Substituted-1,3-Dimethylxanthine Derivatives Department of Pharmaceutical Organic Chemistry 2009
2356 Solution-Phase Synthesis of Small Schiff Bases Combinatorial Library with Potential Antitubercular Activity Department of Medicinal Chemistry 2009
2357 CYTOTOXIC ACTIVITY OF CROTALARIA THEBAICA (DEL) DC. AND MAERUA CRASSIFOLIA GROWING IN EGYPT
Department of Pharmacognosy 2009
2358 Design, Synthesis and Molecular Modeling Study of
Acylated 1,2,4-Triazole-3-Acetates with Potential Anti-
Inflammatory Activity
Department of Medicinal Chemistry 2009
2359 Synthesis and Potential Biological Activities of Certain New
Substituted Thiazoline-Quinoline Derivatives
Department of Pharmaceutical Organic Chemistry 2009
2360 Evaluation of The Pharmacokinetic of New Amantadine Prodrugs As Hepatic Delivery Systems to Enhance Its Activity Against HCV by A New HPLC Method. Department of Pharmaceutical Analytical Chemistry 2009